JP Patent

JP6824549B2 — 経口固形製剤およびその製造法

Assigned to NISSIN PHARMACEUTICAL CO., LTD. · Expires 2021-02-03 · 5y expired

What this patent protects

Patent listed against ribociclib-succinate.

Drugs covered by this patent

ribociclib-succinate (RIBOCICLIB SUCCINATE)

Patent Metadata

Patent number: JP6824549B2
Jurisdiction: JP
Classification: —
Expires: 2021-02-03
Drug substance claim: No
Drug product claim: No
Assignee: NISSIN PHARMACEUTICAL CO., LTD.
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.